The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design.
Saved in:
| Title: | The Acute Stroke or Transient Ischemic Attack Treated with Ticagrelor and Aspirin for Prevention of Stroke and Death (THALES) trial: Rationale and design. |
|---|---|
| Authors: | Johnston SC; Dell Medical School, University of Texas at Austin, Austin, TX, USA., Amarenco P; Department of Neurology and Stroke Centre, Bichat Hospital, Paris Diderot, Paris, France., Denison H; Global Medicines Development, AstraZeneca, Gothenburg, Sweden., Evans SR; Biostatistics Center, George Washington University, Washington DC, MD, USA., Himmelmann A; Global Medicines Development, AstraZeneca, Gothenburg, Sweden., James S; Department of Medical Sciences, Uppsala University, Uppsala, Sweden., Knutsson M; Global Medicines Development, AstraZeneca, Gothenburg, Sweden., Ladenvall P; Global Medicines Development, AstraZeneca, Gothenburg, Sweden., Molina CA; Stroke Unit, Hospital Vall d'Hebron, Barcelona, Spain., Wang Y; Department of Neurology, Beijing Tiantan Hospital, Beijing, China. |
| Corporate Authors: | THALES Investigators |
| Source: | International journal of stroke : official journal of the International Stroke Society [Int J Stroke] 2019 Oct; Vol. 14 (7), pp. 745-751. Date of Electronic Publication: 2019 Feb 12. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Clinical Trial Protocol |
| Journal Info: | Publisher: SAGE Publications Country of Publication: United States NLM ID: 101274068 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4949 (Electronic) Linking ISSN: 17474930 NLM ISO Abbreviation: Int J Stroke Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
